GZMB and ovarian carcinoma: Given the enhanced secretion of granzyme B by T cells and the increased infiltration of T cells into ID8 ovarian tumors following treatment with compound 968, we conclude that compound 968 is an ideal partner to cooperate with immune checkpoint inhibitors in ovarian cancer.